| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer | CFO and COO
2 companies
James H Mackaness is Chief Financial Officer at SLNO and has filed Form 4s across 2 companies. From May 2015 to December 2025, the filings on record show 3 open-market purchases and 14 sales. James H Mackaness's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.2M at current prices.
Historically, James H Mackaness's trades have earned a below-average insider score of 35/100 across 16 rated trades. Over a 12-month horizon, 6.3% of those trades were profitable, with an average 12-month return of -49.5%.
The biggest single holding is SLNO (~$5.2M) as Chief Financial Officer. The SLNO filings lean toward selling, a net 134,906 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | SLNO Soleno Therapeutics Inc | Chief Financial Officer | Buy | 40,000 | $0.00 | - | +146.5% | -11.8% | -36.0% | |
| Sep 13, 2021 | SLNO Soleno Therapeutics Inc | Chief Financial Officer | Buy | 11,235 | $0.89 | $9,981.17 | +70.0% | -35.8% | -84.2% | |
| Jun 26, 2020 | SLNO Soleno Therapeutics Inc | Chief Financial Officer | Buy | 6,060 | $1.65 | $9,999.00 | +60.6% | - | - | |
| Aug 19, 2015 | IRIX Iridex Corp | CFO and COO | Sale+OE | 2,373 | $7.15 | $16,966.95 | -5.0% | - | - | |
| Aug 18, 2015 | IRIX Iridex Corp | CFO and COO | Sale+OE | 4,862 | $7.08 | $34,414.80 | -9.8% | - | - | |
| Aug 14, 2015 | IRIX Iridex Corp | CFO and COO | Sale+OE | 7,765 | $6.99 | $54,243.25 | -15.1% | - | - | |
| May 20, 2015 | IRIX Iridex Corp | CFO and COO | Sale+OE | 2,000 | $9.80 | $19,609.00 | -4.5% | - | - |